✦ LIBER ✦

PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato Trial

✍ Scribed by A. Garcia-Castillo; M. De-los-Rios; A.C. Polanco; M.A. Ramirez; E. Nikolic; C. Mellström

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV45 Long Term Cost-Effectiveness Analy

✍ A. Abaci; E. Bozkurt; C. Mellstrom; B. Caglayan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCV88 Long Term Cost-Effectiveness Analy

✍ J.C. Nicolau; T. Piha; E. Nikolic; K. Rikner; C. Mellström 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCV72 Long-Term Cost Effectiveness Analy

✍ T. Macioch; M. Niewada; P. Perkowski; C. Mellström; A. Budaj 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCV45 Health Economic Evaluation of Tica

✍ L. Delgado-Ortega; J.L. López-Sendón; M. Heras Fortuny; C. Alvarez Sanz; E. Niko 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCV46 LONG-TERM COSTS AND HEALTH OUTCOME

✍ M. Henriksson; E. Nikolic; M. Janzon; O. Hauch; L.Å. Levin; L. Wallentin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV101 IS PRASUGREL COST-EFFECTIVE RELAT

✍ A Davies; M Sculpher; C Schmitt; A Barrett; J Clouth; McCollam PL; A Bakhai 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB